Latest News
Xeris Biopharma Holdings, Inc.
- Xeris Biopharma stock hits 52-week high at 11.38 USD
- Xeris Biopharma Reinforces Leadership in Endocrinology With Data Disclosures Spanning Commercial Portfolio and Pipeline at Multiple Scientific Meetings
- Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
- Xeris Biopharma COO McCulloch sells $141,120 in shares
- H. Lundbeck Said to Eye Xeris Biopharma Acquisition
- Lundbeck Is Said to Express Interest in Xeris Biopharma
- Lundbeck seeks to acquire US pharma company Xeris, media says
- Lundbeck is weighing a bid for Xeris Biopharma, per people familiar
- Xeris Biopharma jumps on report of interest from H Lundbeck
- Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
- Danish drugmaker eyes takeover of Chicago’s Xeris Biopharma
- Lundbeck Is Said To Express Interest In Buying Xeris Biopharma - Bloomberg News
Headlines from the last 30 days, linking to the original publishers. See all market news →